Connection

Alessandro Rambaldi to Antineoplastic Agents, Immunological

Back to Details
This is a "connection" page, showing publications Alessandro Rambaldi has written about Antineoplastic Agents, Immunological.
Alessandro Rambaldi
Connection Strength
0.258
Antineoplastic Agents, Immunological
  1. Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19. Leukemia. 2021 09; 35(9):2710-2714.
    View in: PubMed
    Score: 0.132
  2. Allogeneic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial including Rituximab in the Reduced-Intensity Conditioning Regimen. Biol Blood Marrow Transplant. 2017 Jul; 23(7):1102-1109.
    View in: PubMed
    Score: 0.099
  3. Cord blood-derived cytokine-induced killer cells combined with blinatumomab as a therapeutic strategy for CD19+ tumors. Cytotherapy. 2018 08; 20(8):1077-1088.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.